中文
Home > Brands > Multimedia > In the New Era
中文

  • The signing ceremony of the strategic collaboration between Sinopharm CNPIC and BSBE was held on July 29, 2020.

  • In August 2020, Sinopharm sent a medical team to Iraq to support local clinical treatment.

  • On Sept 21, 2020, CNPIC completed the initial issuance of corporate bonds totaling 600 million yuan ($84.76 million).

  • On Oct 17, 2020, China Traditional Chinese Medicine Holdings Co Ltd and Chongqing Taiji Industry (Group) Co Ltd signed a strategic restructuring agreement in Fuling district, Chongqing.

  • On Oct 27, 2020, China Traditional Chinese Medicine Holdings Co Ltd signed a capital increase cooperation agreement with Chongqing Taiji Industry (Group) Co Ltd for the latter’s strategic restructuring.

  • On Dec 30, 2020, Beijing Institute of Biological Products Co Ltd’s inactivated COVID-19 vaccines became the first in China to receive conditional approval for marketing.

  • On Jan 30, 2021, Sinopharm held a commendation conference for the fight against the COVID-19 pandemic.

  • On Feb 26, 2021, the

  • In March 2021, China Traditional Chinese Medicine Holdings Co Ltd, in collaboration with the China Academy of Chinese Medical Sciences, held a press conference in Beijing to announce the launch of Dampness Resolving and Detoxifying Granules.

  • On May 7, 2021, the inactivated COVID-19 vaccines developed and produced by Sinopharm CNBG's Beijing Institute of Biological Products received emergency use authorization from the World Health Organization.

  • On June 1, 2021, Sinopharm CNBG's Beijing Institute of Biological Products Co Ltd officially supplied the first batch of COVID-19 vaccines to the COVAX initiative, marking the formal delivery of the first batch of COVID-19 vaccines from China to COVAX.

  • An exhibition showcasing China's achievements in scientific and technological innovation during the 13th Five-Year Plan (2016-2020) period was held at the Beijing Exhibition Center from Oct 21 to 27, 2021.

  • In 2022, Sinopharm's Eabeam implemented production measures to ensure the supply of drugs for pandemic prevention and control.

  • A photo taken in 2022 shows researchers working at the Technology Transfer Center of China State Institute of Pharmaceutical Industry Co Ltd.

  • In 2022, the National Advanced Medical Engineering Research Center, whose construction was led by Shanghai Advanced Pharmaceutical Engineering Research Center Ltd, was incorporated into the management of the National Development and Reform Commission.

  • Crown Prince Sheikh Mohammed bin Zayed Al Nahyan of Abu Dhabi of the UAE, who was invited to attend the opening ceremony of the 2022 Beijing Winter Olympic Games, met with Sinopharm Chairman Liu Jingzhen on Feb 5, 2022.

< 1 2 3 4 5 >

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing

Postcode: 100191

Tel: 86-10-82287727

Fax: 86-10-62033332

Links:
Search
Copyright ©  China National Pharmaceutical Group Co Ltd. All rights reserved. Presented by China Daily. 京公网安备 11040102700104号 京ICP备：14023670号-1
Links:
Contact Us

Address: Sinopharm Plaza, No 20 Zhichun Road, Haidian district, Beijing

Postcode: 100191 Tel: 86-10-82287727

Fax: 86-10-62033332

Copyright ©  China National Pharmaceutical Group Co Ltd.
All rights reserved. Presented by China Daily. 京公网安备 11040102700104号
京ICP备：14023670号-1